Search Results
Results found for "Shivani Sachdev"
- 📰 GPCR Weekly News, September 4 to 10, 2023
therapeutic target for substance use disorders Industry News Crinetics’ Once-Daily Oral Paltusotine Achieved
- 📰 GPCR Weekly News, May 8 to 14, 2023
Validation for a Sosei Heptares GPCR Discovery Program Salipro Biotech and DyNAbind Announce Milestone Achievement
- 📰 GPCR Weekly News, January 8 to 14, 2024
OBIO 2024 Investment Summit X-rays to AlphaFold: the future structure of drug discovery Aelis Farma Achieves
- How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology
The shift toward chemical probes became a defining moment in achieving a true GPCR imaging breakthrough
- GPCR Buzz of the Week | Sep 23 - 29, 2024
Let's set sail towards exciting discoveries and groundbreaking achievements together!
- ⛵Sailing the GPCR Seas: Your Weekly Research Voyage! ⦿ Nov 11 - 17, 2024
We are dedicated to enhancing our community and delivering exceptional services to achieve our goal
- 📰 GPCR Weekly News, October 30 to November 4, 2023
First Protein Structures in PDB, Advances Lupus Therapy Research Structure Therapeutics Receives R&D Achievement
- GPCRs are not simple on-off switches: deep dive into GPCR-ligand interactions
On the other hand, selectivity could be achieved by merging both orthosteric and allosteric pharmacophores
- Biotech Startup Failure: Why Teams Drift Off Course Without a Single Wrong Decision
. ✅ The organization is working harder to achieve less clarity .
- How Early Strategic Decision Making Creates Alignment and Better Results
Not because the answers are clear, but because uncertainty is still manageable and alignment is still achievable
- Targeting Intracellular Allosteric Sites in GPCRs
On the other hand, selectivity could be achieved by merging both orthosteric and allosteric pharmacophores
- Unlocking Cell's Secrets: Spontaneous β-Arrestin-Membrane Preassociation Drives Receptor-Activation
GPCRs and β-arrestins and how this complex operates on the plasma membrane of living cells was the goal achieved
- GPCR Updates: Celebrating Breakthroughs, New Course Launches Soon, and Exclusive Discounts! | Aug 26 - Sep 1, 2024
Degradation Modalities A quick revision of how β-adrenergic receptors work and how their antagonists can achieve
- High-Content Screening for GPCR Programs: Overcoming Assay Limitations with Fluorescent Ligands
concentration Exposure times and illumination settings Imaging channel configurations The goal is to achieve
- Illuminating C5aR Biology: The Role of Fluorescent Ligands in GPCR Research
CELT-58 achieved a remarkable EC* 50** of 30.38nM* , while CELT-68 demonstrated high activity in cAMP
- Decoding β-Arrestins: from Structure to function
Cryo-EM, on the other hand, requires less protein and has evolved to achieve resolutions comparable to








